Delivery Order SPE2DB20D1051-SPE2DB25FD7AE

Award Date 2/14/25
Potential Completion Date 2/18/25
Potential Value $6.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Azathioprine 100 mg tablets, a prescription medication. The contract has a firm fixed price of $1,386.37 and is set to expire on August 16, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Azathioprine 50 mg tablets. The contract has a ceiling value of $7,552.83 and runs through October 2024. It is a firm fixed-price contract, with no set-aside designation indicated. AmerisourceBergen also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,316.31 firm-fixed-price contract provides the DLA with 4,562,531,375 units of the pharmaceutical drug Azathioprine 50 mg tablets, which are used to treat various medical conditions. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,036.99, is for the delivery of azathioprine 50 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract provides for the delivery of 4,562,655,027 units of Azathioprine 50 mg tablets. The contract is a Firm Fixed Price arrangement with a ceiling value of $5,050.70 and a completion date of November 1, 2023. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,180.74 firm fixed-price delivery order is for the supply of 4,566,407,951 units of the generic drug Azathioprine 50 mg tablets. The contract has a completion date of November 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a broad range of pharmaceutical products and...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $16,504.37 fixed-price contract is for the supply of azathioprine 50 mg tablets, a specialty medication, to support federal healthcare programs. The award has an ultimate completion date of October 8, 2024 and is not associated with a set-aside. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,560,040,915 units of the generic medication Azathioprine 50 mg tablets. The $2,055.74 firm fixed-price contract has an ultimate completion date of February 24, 2023. The contract is not designated as a set-aside. As an Indefinite Delivery Contract (IDC) holder with the DLA Troop Support Medical worth $999,999,999, AmerisourceBergen...
This is a delivery order award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Azathioprine 50 mg tablets. The award has a ceiling value of $1,309.38 and a performance period through August 20, 2024. This order is placed against an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, which enables the DLA to efficiently procure a wide range of medical commodities, including...
This is a $6,293.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,564,841,028 units of Azathioprine 50 mg tablets in 100-count bottles, with a period of performance through June 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB20D1051
    Indefinite Delivery Contract
  • SPE2DB20D1051-SPE2DB25FD7AE
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,812.37, is for the delivery of Azathioprine 100 mg tablets to support federal healthcare programs.

The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and there is no mention of any major subcontractors. The contract supports the DLA's mission of providing medical supplies and pharmaceuticals to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 5/16/25, 11:44 AM